Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.
2.

Facilitated interaction between the pyruvate dehydrogenase kinase isoform 2 and the dihydrolipoyl acetyltransferase.

Hiromasa Y, Roche TE.

J Biol Chem. 2003 Sep 5;278(36):33681-93. Epub 2003 Jun 18.

4.

Crystal structure of an asymmetric complex of pyruvate dehydrogenase kinase 3 with lipoyl domain 2 and its biological implications.

Devedjiev Y, Steussy CN, Vassylyev DG.

J Mol Biol. 2007 Jul 13;370(3):407-16. Epub 2007 May 10.

6.

Marked differences between two isoforms of human pyruvate dehydrogenase kinase.

Baker JC, Yan X, Peng T, Kasten S, Roche TE.

J Biol Chem. 2000 May 26;275(21):15773-81.

8.
10.
11.

Structural determinants for cross-talk between pyruvate dehydrogenase kinase 3 and lipoyl domain 2 of the human pyruvate dehydrogenase complex.

Tso SC, Kato M, Chuang JL, Chuang DT.

J Biol Chem. 2006 Sep 15;281(37):27197-204. Epub 2006 Jul 18.

14.
15.
17.

Pyruvate dehydrogenase kinase isoform 2 activity stimulated by speeding up the rate of dissociation of ADP.

Bao H, Kasten SA, Yan X, Hiromasa Y, Roche TE.

Biochemistry. 2004 Oct 26;43(42):13442-51.

PMID:
15491151
18.

Reaction mechanism for mammalian pyruvate dehydrogenase using natural lipoyl domain substrates.

Liu S, Gong X, Yan X, Peng T, Baker JC, Li L, Robben PM, Ravindran S, Andersson LA, Cole AB, Roche TE.

Arch Biochem Biophys. 2001 Feb 15;386(2):123-35.

PMID:
11368334
20.

Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex.

Kato M, Chuang JL, Tso SC, Wynn RM, Chuang DT.

EMBO J. 2005 May 18;24(10):1763-74. Epub 2005 Apr 28.

Supplemental Content

Support Center